Sources say GlaxoSmithKline (GSK) is poised to buy Human Genome Sciences (HGSI) for ~$2.8B, with...

|About: GlaxoSmithKline (GSK)|By:, SA News Editor

Sources say GlaxoSmithKline (GSK) is poised to buy Human Genome Sciences (HGSI) for ~$2.8B, with an announcement likely during today's premarket session. The deal terms have reportedly been sweetened to $14/share from $13/share.